Medicinal composition containing cinnabar or/and realgar
A technology of composition and cinnabar, applied in the direction of drug combination, medical preparations containing active ingredients, drug delivery, etc., can solve the problems of laborious, difficult to retain active ingredients, energy consumption, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0012] See Table 1 for the results of the acute toxicity test on mice of realgar A treated with the technology disclosed in our invention patent 2006102000675 and realgar B treated with the water-flying method.
[0013] mineral medicine
Embodiment 2
[0015] Add different amounts of cinnabar and realgar treated with the technology disclosed in the invention patent 2006102000675 and Niuhuang Angong Pills with cinnabar and realgar treated with the prior art, the effect on cerebral infarction in rats with middle cerebral artery embolism: 40 SD rats , divided into 4 groups, 10 rats in each group, administered 1.0ml / 100g according to body weight, and the control group and model group were given equal volume of water, and the administration was continued for 3 days. One hour after administration on the second day, focal cerebral ischemia was induced in rats by ferric chloride method, and the cerebral infarction area of rats was measured. The results are shown in Table 2.
[0016] test group
Embodiment 3
[0018] Add different amounts of cinnabar and realgar (every 100ml contains cinnabar with a total mercury content of 0.005% and realgar with a total arsenic content of 0.005% treated by a bacterial method) of Qingkailing processed by the technology disclosed in the invention patent 2006102000675 Oral solution, the control group and the model group were given an equal volume of water, and administered by intragastric administration for 3 consecutive days. One hour after administration on the second day, focal cerebral ischemia was induced in rats by ferric chloride method, and the cerebral infarction area of rats was measured. The results are shown in Table 3.
[0019] test group
[0020] *diluted to 1.5ml
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com